This document is intended as a supplement to the EANM “Guidelines on current Good Radiopharmacy Practice (cGRPP)” issued by the Radiopharmacy Committee of the EANM (Gillings et al. in EJNMMI Radiopharm Chem. 6:8, 2021). The aim of the EANM Radiopharmacy Committee is to provide a document that describes how to manage risks associated with small-scale “in-house” preparation of radiopharmaceuticals, not intended for commercial purposes or distribution.
Gillings, N., Hjelstuen, O., Behe, M., Decristoforo, C., Elsinga, P., Ferrari, V., et al. (2022). EANM guideline on quality risk management for radiopharmaceuticals. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 49(10), 3353-3364 [10.1007/s00259-022-05738-4].
EANM guideline on quality risk management for radiopharmaceuticals
Todde S.Co-ultimo
;
2022
Abstract
This document is intended as a supplement to the EANM “Guidelines on current Good Radiopharmacy Practice (cGRPP)” issued by the Radiopharmacy Committee of the EANM (Gillings et al. in EJNMMI Radiopharm Chem. 6:8, 2021). The aim of the EANM Radiopharmacy Committee is to provide a document that describes how to manage risks associated with small-scale “in-house” preparation of radiopharmaceuticals, not intended for commercial purposes or distribution.
| File | Dimensione | Formato | |
|---|---|---|---|
|
Gillings-2022-Eur J Nuclear Med Molecul Imag-VoR.pdf
accesso aperto
Descrizione: Guidelines
Tipologia di allegato:
Publisher’s Version (Version of Record, VoR)
Licenza:
Creative Commons
Dimensione
851.78 kB
Formato
Adobe PDF
|
851.78 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
